Home > Resources > Whitepapers > Life science and Biotechnology

Life science and Biotechnology

Life sciences and biotechnology are widely recognised to be, after information technology, the next wave of the knowledge-based economy, creating new opportunities for our societies and economies.

Spotlight

Harvard Stem Cell Institute

The Harvard Stem Cell Institute (HSCI) brings together more than 1000 scientists in the schools and affiliated hospitals of Harvard to fund novel research and implement collaborative academic and industrial models for advancing stem cell biology into the clinic.

OTHER WHITEPAPERS

bFGF Supports Human ES Cell Self-Renewal

whitePaper | March 24, 2023

Basic fibroblast growth factor (bFGF) is an important cytokine used to support the growth and self renewal of human embryonic stem cells.

Eliminate Noisy Oxygen Measurements in Bioreactors

whitePaper | March 27, 2023

Controlling the dissolved oxygen level in fermentation vessels and bioreactors is vital to maximizing production yield and ensuring high end-product quality.

Gene, Cell, & RNA Therapy Landscape

whitePaper | January 24, 2022

The American Society of Gene & Cell Therapy (ASGCT) is the primary professional membership organization.

Liposomal and Nanoparticle Technology at Pfizer Melbourne

whitePaper | November 22, 2022

Specializing in oncology, anti-infective and complex formulations, Pfizer Melbourne provides end-to-end services from development through to commercial manufacture of sterile dosage forms.

State of the Global Biotech Landscape

whitePaper | November 22, 2022

Over the last five years, the global biotech and pharmaceutical landscape has witnessed continued growth. The analysis period encompasses a unique timeframe including the global COVID-19 pandemic.

Effective solutions for global challenges

whitePaper | April 24, 2023

Despite challenging global conditions, the Swiss biotech industry was able to raise more than CHF 1.33 billion in 2022, with roughly CHF 0.78 billion collected by public companies and the remaining CHF 0.55 billion collected by private companies.

bFGF Supports Human ES Cell Self-Renewal

whitePaper | March 24, 2023

Basic fibroblast growth factor (bFGF) is an important cytokine used to support the growth and self renewal of human embryonic stem cells.

Eliminate Noisy Oxygen Measurements in Bioreactors

whitePaper | March 27, 2023

Controlling the dissolved oxygen level in fermentation vessels and bioreactors is vital to maximizing production yield and ensuring high end-product quality.

Gene, Cell, & RNA Therapy Landscape

whitePaper | January 24, 2022

The American Society of Gene & Cell Therapy (ASGCT) is the primary professional membership organization.

Liposomal and Nanoparticle Technology at Pfizer Melbourne

whitePaper | November 22, 2022

Specializing in oncology, anti-infective and complex formulations, Pfizer Melbourne provides end-to-end services from development through to commercial manufacture of sterile dosage forms.

State of the Global Biotech Landscape

whitePaper | November 22, 2022

Over the last five years, the global biotech and pharmaceutical landscape has witnessed continued growth. The analysis period encompasses a unique timeframe including the global COVID-19 pandemic.

Effective solutions for global challenges

whitePaper | April 24, 2023

More Whitepapers

Life science and Biotechnology

Spotlight

Harvard Stem Cell Institute

OTHER WHITEPAPERS

bFGF Supports Human ES Cell Self-Renewal

Eliminate Noisy Oxygen Measurements in Bioreactors

Gene, Cell, & RNA Therapy Landscape

Liposomal and Nanoparticle Technology at Pfizer Melbourne

State of the Global Biotech Landscape

Effective solutions for global challenges

bFGF Supports Human ES Cell Self-Renewal

Eliminate Noisy Oxygen Measurements in Bioreactors

Gene, Cell, & RNA Therapy Landscape

Liposomal and Nanoparticle Technology at Pfizer Melbourne

State of the Global Biotech Landscape

Effective solutions for global challenges

Spotlight

Harvard Stem Cell Institute

Events